News
Sun Pharmaceutical stated that its subsidiaries Sun Pharmaceutical Industries (SPII) and Taro Pharmaceuticals USA (Taro) have ...
Sun Pharmaceutical Industries Ltd. has announced that its U.S. subsidiaries, Sun Pharmaceutical Industries Inc. and Taro ...
Under the agreement, Sun Pharmaceutical Industries, Inc. and Taro will make a combined payment of $200 million in exchange for a full release of all claims brought against them by the End Purchaser ...
Mumbai: Sun Pharmaceutical Industries Limited has announced the incorporation of a subsidiary company, Sun Pharma (Hainan) ...
A new study offers insights into the relative efficacy of various treatments for alopecia areata (AA), suggesting that deuruxolitinib (Leqselvi; Sun Pharma) at a dosage of 12 mg twice daily for 24 ...
With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help ...
Leqselvi ™ (deuruxolitinib) is now available for the treatment of adults with severe alopecia areata.
Sun Pharmaceutical Industries, announced its release of Leqselvi in the U.S. earlier this week. Leqselvi™ is currently ...
MUMBAI: India’s equity benchmarks snapped a four-session losing streak on Tuesday, as lower-than-expected domestic inflation ...
The stigma of having alopecia causes more depression and anxiety than the disease itself, new research has found.
14d
Capital Market on MSNSun Pharma launches Leqselvi in US; settles litigation with Incyte CorpThe drug is indicated for the treatment of alopecia areata - a condition in which the immune system attacks hair follicles, leading to hair loss on the scalp as well as other parts of the body.
Shares of HDFC Life Insurance, HDB Financial, ICICI Lombard, Just Dial will remain in focus as companies will declare Q1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results